scholarly journals Response and Remission Rates in Internet-Based Cognitive Behavior Therapy: An Individual Patient Data Meta-Analysis

2019 ◽  
Vol 10 ◽  
Author(s):  
Gerhard Andersson ◽  
Per Carlbring ◽  
Alexander Rozental
Keyword(s):  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Individual Patient Data ◽  
Meta Analysis ◽  
Patient Data ◽  
Cognitive Behavior ◽  
Remission Rates

scholarly journals Efficacy and Acceptability Comparisons of Cognitive Behavior Therapy, Drugs, and Their Combination for Panic Disorder in Adults: a Network Meta-analysis

2020 ◽  
Author(s):  
Fengjie Gao ◽  
Hairong He ◽  
Bin Yan ◽  
Jian Yang ◽  
Yajuan Fan ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Remission Rate ◽  
Meta Analysis ◽  
The Other ◽  
Cognitive Behavior ◽  
Oral Drugs ◽  
Randomized Controlled ◽  
Remission Rates

AbstractObjectiveTo compare 22 oral drugs, cognitive behavior therapy (CBT), and their combination treatments for the acute treatment of adults with panic disorder in terms of remission rate and acceptability.DesignSystematic review and network meta-analysisData sourcesPubMed, Web of Science, Cochrane Central Register of Controlled Trials, and Embase databases from their inception up to May 26, 2019.Study selectionRandomized controlled clinical trials (RCTs) of any oral drugs, CBT, CBT combined with any drug, or placebo in the acute treatment of adults with panic disorder diagnosed according to standard operationalized criteria. The primary outcomes were efficacy (remission rate) and acceptability (treatment discontinuations due to any cause).ResultsWe identified 6585 reports that included 68 full-text RCTs involving 11101 patients. In terms of efficacy, 13 (68%) of 19 interventions were associated with higher remission rates than those of for placebo, with ORs ranging from 2.1 (95% credible interval [CrI] = 1.1 to 4.0) for sertraline to 13 (CrI = 4.5 to 44) for CBT combined with any drug. Regarding acceptability, alprazolam, imipramine, and etizolam were associated with lower dropout rates, with ORs ranging from 0.23 (CrI = 0.15 to 0.33) for alprazolam to 0.076 (CrI = 0.0021 to 0.77) for etizolam. Most of the differences between the other interventions were unclear. In head-to-head analyses, CBT combined with any drug was more effective than the other interventions, but it was no associated with an improvement in acceptability (OR = 0.12 to 0.219).ConclusionsCBT combined with any drug was more effective than the other interventions analyzed in this study. CBT alone did not differ significantly from other drugs alone. We found that most drugs are effective against panic disorder, but they exhibit different acceptability and tolerability profiles.What is already known on this topicSome randomized controlled trials indicated that combined therapy are more effective than drug alone or cognitive behavior therapy alone. Nevertheless, drug monotherapy, cognitive behavior therapy, and combination therapy had never been compared in a comprehensive network meta-analysis. With this evidence gap remaining, the availability of reliable evidence of the relative merits of multiple interventions is essential to ensuring that clinicians choose the best option for each individual patient.What this study addsThis network meta-analysis is the first to evaluate the relative merits of cognitive behavior therapy, cognitive behavior therapy combined with any drug, and 22 oral drugs in the field of panic disorder. The results showed a significant higher remission rates for cognitive behavior therapy combined with any drug than those of the other interventions. Cognitive behavior therapy alone was superior to placebo but did not differ significantly from other active drugs. Additionally, paroxetine, venlafaxine, fluoxetine, sertraline, and clonazepam are more recommendable than the other drugs based on their remission rates, scores on panic-symptoms scales, and acceptability.

scholarly journals Cognitive behavior therapy combined with exercise for adults with chronic diseases: Systematic review and meta-analysis.

2018 ◽  
Vol 37 (5) ◽  
pp. 433-450 ◽  
Author(s):  
Paquito Bernard ◽  
Ahmed-Jérôme Romain ◽  
Johan Caudroit ◽  
Guillaume Chevance ◽  
Marion Carayol ◽  
...  
Keyword(s):  
Systematic Review ◽  
Chronic Diseases ◽  
Behavior Therapy ◽  
Cognitive Behavior Therapy ◽  
Meta Analysis ◽  
Cognitive Behavior
Sign in / Sign up

Export Citation Format

Share Document